Navigation Links
Largest synthetic gene ever built offers insights into anti-malarial drug resistance

ion with investigators at the National Institutes of Health, described in 2000 that the PfCRT gene is primarily responsible for the vast majority of drug resistance that leads to human death from malaria. Earlier this year, they also helped describe how the gene PfNHE likely contributes, and this turns out not to be as vital as PfCRT. Now, based in part on this study, they know that PfMDR1 is dependent on mutated PfCRT, and probably doesn't act independently.

"The contribution of PfMDR1 to anti-malarial drug resistance is important, but much smaller than what many researchers thought it would be," said Roepe. "Before the discovery of PfCRT, many thought PfMDR1 would be the primary culprit."

Roepe, and his two other co-authors, Georgetown researchers Linda Amoah, PhD, and Jacqueline Lekostaj, an MD/PhD student at Lombardi Comprehensive Cancer Center, employed an unusual method to construct the PfMDR1 gene. They first obtained the PfMDR1 protein sequence from the NIH PubMed data base. They then "back translated" the protein sequence using a computer program to change the parasite gene sequence − which combines nucleotide base pairs in a way that is found in no other life form − into one that could be "read" by yeast. The yeast are then able to produce the PfMDR1 protein, in its proper sequence, from this synthetic gene. They previously used this same technique to create and express a synthetic version of the much smaller PfCRT gene. PfMDR1 is made up of about 4,000 base pairs and its protein is particularly large, Roepe said, making the recent work much more challenging.

Already, analysis of these three anti-malarial drug resistance genes is painting a picture of how the parasite escapes destruction by most of the agents now used against it, he said.,

When a malaria parasite is transmitted through a mosquito bite, the mosquito injects the parasite into skin or blood, which then travels to the liver within minutes, grows
'"/>

Source:Georgetown University Medical Center


Page: 1 2 3 4

Related biology news :

1. Largest computational biology simulation mimics life’s most essential nanomachine
2. Largest study of human interactome reveals a novel way
3. Largest genomic search finds genes that may contribute to autism
4. Inexpensive, mass-produced genes core of synthetic biology advances at UH
5. Researchers find promising cancer-fighting power of synthetic cell-signaling molecule
6. Tagging pathogens with synthetic DNA barcodes
7. Breakthrough in micro-device fabrication combines biology and synthetic chemistry
8. Heparin prepared synthetically could replace animal-derived drug
9. Williams College biologist explores photosynthetic apparatus
10. New synthetic self-assembling macromolecules mimic nature
11. Locusts built-in surface analysis ability directs them to fly overland

Post Your Comments:
(Date:11/3/2009)...l of Engineering and Applied Science have for the ...atory the enzyme responsible for producing the blo..., The research, published Oct. 23 in the journal...ent of other compounds with similarly beneficial e...is one of the most interesting but least understoo...
(Date:11/3/2009)...Chicago have received $1 million from the National...tionship between "fat taxes" and food consumption,... two-year project was made available through the A... The study will link state tax rates associated wi...den foods and beverages (soda, candy, baked goods ...
(Date:11/3/2009)...ense Corporation, the company that created the fir...t technology, today announced the completion of a ...vestment from Technology Partners with existing in... This funding will allow EmSense to continue its g...arch partners. The funds will also enable the com...
Breaking Biology News(10 mins):UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2UIC receives $1 million grant to study 'fat taxes,' diet, obesity 2EmSense Raises $9 Million Series C Round of Financing 2Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility 14603 1Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility 14603 2Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility 14603 3Denver Ft Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens 5735 1Denver Ft Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens 5735 2Denver Ft Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens 5735 3West to Host 2009 Third Quarter Conference Call 5733 1West to Host 2009 Third Quarter Conference Call 5733 2
...ary 21, 2008)- Jizhou Song, a professor in the Uni...ollaborators Professor John Rogers, at the Univers...orthwestern University have developed a new design...round complex shapes, without a reduction in elect...egy is based on semiconductor nanomaterials that c...
...t the University of Delaware seeks to determine wh...lives in seawater and is related to the bacterium ...rulence. , V. parahaemolyticus is a leading cau...ntly associated with the consumption of raw or und...ollusks, and crabs. Victims typically suffer from ...
... is head versus heart, the heart comes first. The ...l in supplying blood to the rest of the body. Yet,...regulate the heartbeat. By studying chickens, hear...fied certain proteins within the heart muscle that...artbeat control. Understanding these components an...
Other Biology News:University of Miami engineer designs stretchable electronics with a twist 2UD research study to shed light on emerging seaborne pathogen 2UD research study to shed light on emerging seaborne pathogen 3Researchers examine developing hearts in chickens to find solutions for human heart abnormalities 2
(Date:11/6/2009)... Intarcia Therapeutics, Inc. delivered two present...us delivery of exenatide) program for the treatmen...Technology Meeting in San Francisco, CA: ,, (Lo...SFTU126LOGO ) ,, Continuous Subcutaneous Deli...se, HbA1c and Reduces Weight in a 28-day Phase 1b ...
(Date:11/5/2009)...irstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today a...er ended September 30, 2009. GenVec reported a net...ree months ended September 30, 2009 compared to a ...comparable quarter of 2008. For the nine months en...1 million ($0.15 per share), compared to a net los...
(Date:11/5/2009).../ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX), ...d CEO of Imagenetix, will be presenting the Compan... Thursday, December 3rd, at 10:30 AM PST at the Lu..., LD MICRO is a by-invitation only newsletter fir... the micro-cap space. Since 2002, the firm has pub...
(Date:11/5/2009)...ll/ -- Transgenomic, Inc. (OTC Bulletin Board: TBI...er ended September 30, 2009. The Company,s financi.... ,, Third Quarter 2009 ,, The Company rep...r the third quarter of 2009 as compared to a net l...uarter of 2008. ,, Net sales were $5.0 million...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...ing to spots on a plastic slide. Source: National... Wis. Five small business innovation research (SB...warded to GenTel BioSurfaces, Inc. this year by th...cience Foundation, company officials announced Tue...duct development focused on biochip development in...
...eived a $500,000 federal research grant, the compa...ase II small-business innovation research grant fr...ork on an antibacterial treatment. The funding com...ceived last year for the same technology. , ,Accor...cer, the grant will help fund the fight against re...
...anufacturing Outreach Center MENOMONIE, Wis. The...r at the University of Wisconsin-Stout was rece...ommerce and the National Institute for Standards...resentation for several distinctions. , ,The cente... branches of Manufacturing Extensionship Partnersh...
Other Biology Technology:GenTel claims $900,000 in federal grants this year for biochip research 2ConjuGon receives $500,000 to battle bacteria 2
PCR Optimizer Kit from Invitrogen
Mouse Anti-Human VEGFB Monoclonal Antibody, Unconjugated, Clone 4H5 from Abnova Corporation
...Infinite 200 series of microplate readers combines...e or absorbance detection in an affordable, easy-t...nce applications. The unique modular design and ad...earchers with a choice of a monochromator (M200) o...
RNA 6000 Nano Chip Kit from Agilent Technologies
Biology Products: